Julie Arasse

Physiogenex

Physiogenex is a leading preclinical contract research organization (CRO) specializing in metabolic disorders such as diabetes, obesity, liver diseases, dyslipidemia, atherosclerosis and cardiovascular complications. We offer outstanding consultancy and research services and we provide our clients with an unique research platform combining diet induced animal models and cutting-edge technology: - Ex vivo and in vivo primary screening : large scale experiments with diet-induced, genetic animal models or a combination of models - In vivo pharmacology studies based on diet-induced & predictive animal models combined to state of the art experiments in rodents. Physiogenex also develops innovative diet-animal models and technologies like the ox-LDL RCT assay.